RNU7-40P

Across TCGA pan-cancer cohorts, RNU7-40P RNA differs between tumor and matched normal tissue in 10 of 18 cancer types tested, making tumor–normal expression one of RNU7-40P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RNU7-40P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU7-40P is over-expressed in tumor.

STAD, LIHC, and LUSC are the cancer types where RNU7-40P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU7-40P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	+1.200	.001	7	view →
LIHC	All	All	+0.467	.002	5	view →
LUSC	All	All	+0.591	.003	3	view →
HNSC	All	II,III,IV	+0.435	.025	3	view →
ESCA	All	II,III,IV	+2.045	.014	2	view →
READ	All	All	+1.165	.008	2	view →
KIRC	All	All	+0.314	.019	2	view →
CHOL	Female	All	+1.223	.001	1	view →
BLCA	All	IV	+1.141	.042	1	view →
LUAD	Female	All	+0.514	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 10 strongest of 10 lineages.

RNU7-40P–STAD

Open the STAD breakdown →